2019
DOI: 10.1002/wrna.1573
|View full text |Cite
|
Sign up to set email alerts
|

The potential of engineered eukaryotic RNA‐binding proteins as molecular tools and therapeutics

Abstract: Eukaroytic RNA‐binding proteins (RBPs) recognize and process RNAs through recognition of their sequence motifs via RNA‐binding domains (RBDs). RBPs usually consist of one or more RBDs and can include additional functional domains that modify or cleave RNA. Engineered RBPs have been used to answer basic biology questions, control gene expression, locate viral RNA in vivo, as well as many other tasks. Given the growing number of diseases associated with RNA and RBPs, engineered RBPs also have the potential to se… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 159 publications
0
13
0
Order By: Relevance
“…It is clear that RBPs function sequentially to post-transcriptionally regulate gene expression at different steps of myogenesis, in much the similar manner as different myogenic transcription factors that promote myoblast proliferation, myogenic differentiation and satellite cell quiescence at the transcription level. Given the growing number of muscular disorders associated with RNAs and RBPs, understanding the functional implication of RBPs in different steps of muscle development may have the potential to use them as therapeutics ( Shotwell et al, 2020 ). However, there are also many fundamental questions that remain open for further investigations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is clear that RBPs function sequentially to post-transcriptionally regulate gene expression at different steps of myogenesis, in much the similar manner as different myogenic transcription factors that promote myoblast proliferation, myogenic differentiation and satellite cell quiescence at the transcription level. Given the growing number of muscular disorders associated with RNAs and RBPs, understanding the functional implication of RBPs in different steps of muscle development may have the potential to use them as therapeutics ( Shotwell et al, 2020 ). However, there are also many fundamental questions that remain open for further investigations.…”
Section: Discussionmentioning
confidence: 99%
“…Altogether, these observations definitely illustrate the importance of RBPs-regulated networks in skeletal muscle physiopathology. Thus, they present the potential to be served as clinically relevant disease-related biomarkers and as therapeutics ( Shotwell et al, 2020 ).…”
Section: An Overview Of Post-transcriptional Regulation In Muscle Developmentmentioning
confidence: 99%
“…These approaches are mainly explored in humans, in the context of targeted drug delivery therapeutics. Interesting examples are mammalian lipoproteins, which are often proposed for use in human siRNAs delivery [ 244 , 245 , 246 , 247 , 248 , 249 ]. In addition, a high percentage of mammalian extracellular miRNAs are bound to Ago proteins, and pre-assembled siRNA-Ago complexes, delivered via different carriers, can increase the gene silencing effect in mice [ 180 , 181 , 182 , 250 ].…”
Section: Biotechnological Prospectsmentioning
confidence: 99%
“…Of note, these systems are amenable to be combined with regulatory proteins to attain complex dynamic behaviors [16]. A heterologous RRM-containing protein with definite regulatory activity, in addition to provide empirical evidence on the adaptability of such RNA-binding domains to different genetic backgrounds, would enlarge the synthetic biology toolkit [17], boosting applications in which high orthogonality, expression fine-tuning, and signal integrability are required features. In addition, RRMs can themselves be allosterically regulated, opening up new avenues for post-transcriptional regulation by small molecules.…”
Section: Introductionmentioning
confidence: 99%